These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32265370)

  • 1. Anakinra in Recurrent Pericarditis: Current Evidence on Clinical Use, Effectiveness, and Safety.
    Correia ETO; Dos Santos Barbetta LM; de Almeida JPCL; Mesquita ET
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):42-49. PubMed ID: 32265370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
    Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
    Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment.
    Lopalco G; Rigante D; Cantarini L; Imazio M; Lopalco A; Emmi G; Venerito V; Fornaro M; Frediani B; Nivuori M; Brucato A; Iannone F
    Trends Cardiovasc Med; 2021 Jul; 31(5):265-274. PubMed ID: 32376492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis.
    Wohlford GF; Buckley LF; Vecchié A; Kadariya D; Markley R; Trankle CR; Chiabrando JG; de Chazal HM; Van Tassell B; Abbate A
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):50-52. PubMed ID: 32398478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis.
    Andreis A; Imazio M; Giustetto C; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1561-1565. PubMed ID: 32868281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 Blockers for the Treatment of Recurrent Pericarditis: Pathophysiology, Patient-Reported Outcomes, and Perspectives.
    Thomas GK; Bonaventura A; Vecchié A; van Tassell B; Imazio M; Klein A; Luis SA; Abbate A
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):503-510. PubMed ID: 37163222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.
    Imazio M; Andreis A; De Ferrari GM; Cremer PC; Mardigyan V; Maestroni S; Luis SA; Lopalco G; Emmi G; Lotan D; Marcolongo R; Lazaros G; De Biasio M; Cantarini L; Dagna L; Cercek AC; Pivetta E; Varma B; Berkson L; Tombetti E; Iannone F; Prisco D; Caforio ALP; Vassilopoulos D; Tousoulis D; De Luca G; Giustetto C; Rinaldi M; Oh JK; Klein AL; Brucato A; Adler Y
    Eur J Prev Cardiol; 2020 Jun; 27(9):956-964. PubMed ID: 31610707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children.
    Signa S; D'Alessandro M; Consolini R; Miniaci A; Bustaffa M; Longo C; Tosca MA; Bizzi M; Caorsi R; Mendonça LO; Pession A; Ravelli A; Gattorno M
    Pediatr Rheumatol Online J; 2020 Jun; 18(1):51. PubMed ID: 32546242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
    Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
    Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anakinra as rescue therapy for steroid-dependent idiopathic recurrent pericarditis in children: case report and literature review.
    Rodriguez-Gonzalez M; Ruiz-Gonzalez E; Castellano-Martinez A
    Cardiol Young; 2019 Feb; 29(2):241-243. PubMed ID: 30511600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.
    Tomelleri A; Cavalli G; De Luca G; Campochiaro C; D'Aliberti T; Tresoldi M; Dagna L
    Front Immunol; 2018; 9():1233. PubMed ID: 29910817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases.
    Lazaros G; Vasileiou P; Koutsianas C; Antonatou K; Stefanadis C; Pectasides D; Vassilopoulos D
    Ann Rheum Dis; 2014 Dec; 73(12):2215-7. PubMed ID: 25165036
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.
    Brucato A; Emmi G; Cantarini L; Di Lenarda A; Gattorno M; Lopalco G; Marcolongo R; Imazio M; Martini A; Prisco D
    Intern Emerg Med; 2018 Jun; 13(4):475-489. PubMed ID: 29633070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anakinra: an emerging option for refractory idiopathic recurrent pericarditis: a systematic review of published evidence.
    Lazaros G; Imazio M; Brucato A; Vassilopoulos D; Vasileiou P; Gattorno M; Tousoulis D; Martini A
    J Cardiovasc Med (Hagerstown); 2016 Apr; 17(4):256-62. PubMed ID: 26090915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis.
    Abadie BQ; Cremer PC
    BioDrugs; 2022 Jul; 36(4):459-472. PubMed ID: 35639340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis.
    Finetti M; Insalaco A; Cantarini L; Meini A; Breda L; Alessio M; D'Alessandro M; Picco P; Martini A; Gattorno M
    J Pediatr; 2014 Jun; 164(6):1425-31.e1. PubMed ID: 24630353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of anakinra for idiopathic and non-idiopathic pericarditis refractory or intolerant to conventional therapy.
    Shaukat MH; Singh S; Davis K; Torosoff M; Peredo-Wende R
    Eur Heart J Acute Cardiovasc Care; 2020 Dec; 9(8):888-892. PubMed ID: 32159368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of Interleukin-1 Receptor Antagonists in Patients With Recurrent Pericarditis.
    Khayata M; Shah NP; Verma BR; Giugni AS; Alkharabsheh S; Asher CR; Imazio M; Klein AL
    Am J Cardiol; 2020 Jul; 127():184-190. PubMed ID: 32416963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra).
    Vassilopoulos D; Lazaros G; Tsioufis C; Vasileiou P; Stefanadis C; Pectasides D
    Int J Cardiol; 2012 Sep; 160(1):66-8. PubMed ID: 22704870
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of an interleukin-1β receptor antagonist (anakinra) in idiopathic recurrent pericarditis.
    Scardapane A; Brucato A; Chiarelli F; Breda L
    Pediatr Cardiol; 2013; 34(8):1989-91. PubMed ID: 23052671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.